Department of Cardiology, Robert-Bosch-Hospital, 70376 Stuttgart, Germany.
Heart Centre Bremen, Kardiologisch-Angiologische Praxis, 28211 Bremen, Germany.
Medicina (Kaunas). 2021 Jul 30;57(8):776. doi: 10.3390/medicina57080776.
Atrial fibrillation (AF) is the most common arrythmia of the human heart. Patients mostly present highly symptomatic with dyspnea and tachycardia and have a disproportionate risk of developing heart failure or stroke events. We aimed to evaluate the determinants of early conversion into sinus rhythm during initial stay at the emergency department of a large tertiary care center. A total of 1384 subjects with recent-onset AF were recruited between October 2014 and April 2017. Patients with longstanding AF were excluded, resulting in a total of 935 patients for the present analysis. In multivariate adjusted logistic regression analyses, previous catheter ablation therapy was a strong predictor of conversion in sinus rhythm during the stay in the emergency department, with an odds ratio (OR) of 3.87 (95% CI 2.40, 6.54; < 0.001). In contrast, existing antiarrhythmic medication showed no association with facilitated conversion [OR 0.89 (95%CI 0.65, 1.20); = 0.44]. Likewise, conventional cardiovascular risk factors (hypertension, dyslipidemia, diabetes) were also not associated with conversion during hospital stay. This is the first report on the relevance of previous ablation therapy for early restoration of sinus rhythm in recent-onset AF. Although catheter ablation is associated with relevant risk of late recurrence of atrial fibrillation, it seems to have a large benefit for patients with recent-onset AF.
心房颤动(AF)是人类心脏最常见的心律失常。患者主要表现为呼吸困难和心动过速等高度症状,并且发生心力衰竭或中风事件的风险不成比例地增加。我们旨在评估在大型三级护理中心急诊部首次入住期间早期转为窦性心律的决定因素。
在 2014 年 10 月至 2017 年 4 月期间,共招募了 1384 例新发 AF 患者。排除了长期 AF 患者,因此共有 935 例患者进行了本分析。在多变量调整的逻辑回归分析中,先前的导管消融治疗是急诊部期间转为窦性心律的强有力预测因素,优势比(OR)为 3.87(95%CI 2.40,6.54;<0.001)。相比之下,现有的抗心律失常药物与促进转化无关[OR 0.89(95%CI 0.65,1.20);=0.44]。同样,传统的心血管危险因素(高血压、血脂异常、糖尿病)也与住院期间的转化无关。
这是第一项关于先前消融治疗对新发 AF 中早期窦性心律恢复相关性的报告。尽管导管消融与心房颤动晚期复发的相关风险相关,但它似乎对新发 AF 患者有很大的益处。